BOB Capital Markets Ltd.
Sun Pharma (SUNP) reported a healthy Q2 beat: 6% on sales, 32% on EBITDA.
Sun Pharmaceutical Industries Ltd.'s price crossed below 30Day SMA today
More from Sun Pharmaceutical Industries Ltd.
Recommended